Review of the status of neoadjuvant therapy in HER2-positive breast cancer

PURPOSE: The development of human epidermal growth factor receptor 2 (HER2)-directed therapies has revolutionized the treatment of HER2-positive breast cancer. The aim of this article is to review the continually evolving treatment strategies in the neoadjuvant setting of HER2-positive breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Dowling, Gavin P., Keelan, Stephen, Toomey, Sinead, Daly, Gordon R., Hennessy, Bryan T., Hill, Arnold D. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923093/
https://www.ncbi.nlm.nih.gov/pubmed/36793602
http://dx.doi.org/10.3389/fonc.2023.1066007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923093/
https://www.ncbi.nlm.nih.gov/pubmed/36793602
http://dx.doi.org/10.3389/fonc.2023.1066007

Ejemplares similares